← Back to Search

Oculomotor and Vestibular Assessment

Treatment for Healthy Subjects

N/A
Waitlist Available
Led By Aura Kullmann, PhD
Research Sponsored by Neurolign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This trial will test a device that records eye movements in response to visual and auditory stimuli, in order to better understand neural brain pathways related to OVRT-C development.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Normative data for I-PAS tests
Secondary outcome measures
Goggle evaluation

Find a Location

Who is running the clinical trial?

NeurolignLead Sponsor
7 Previous Clinical Trials
1,442 Total Patients Enrolled
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER
47 Previous Clinical Trials
12,479 Total Patients Enrolled
University of MiamiOTHER
898 Previous Clinical Trials
409,051 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Normative Oculomotor and Vestibular Data in Pediatric Population
2021. "Normative Oculomotor and Vestibular Data in Pediatric Population". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04107610.
~150 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top